Highlights and Quick Summary
- Long-Term Investments Change (Net) for the quarter ending September 30, 2022 was $148 Million (a 238.54% increase compared to previous quarter)
- Year-over-year quarterly Long-Term Investments Change (Net) increased by 506.57%
- Annual Long-Term Investments Change (Net) for 2021 was $-166 Million (a 329.38% increase from previous year)
- Annual Long-Term Investments Change (Net) for 2020 was $-38.7 Million (a -81.82% decrease from previous year)
- Twelve month Long-Term Investments Change (Net) ending September 30, 2022 was $345 Million (a 15.84% increase compared to previous quarter)
- Twelve month trailing Long-Term Investments Change (Net) decreased by -307.56% year-over-year
Trailing Long-Term Investments Change (Net) for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $345 Million | $298 Million | $243 Million | $-166 Million |
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-Term Investments Change (Net) of BridgeBio Pharma, Inc.
Most recent Long-Term Investments Change (Net)of BBIO including historical data for past 10 years.Interactive Chart of Long-Term Investments Change (Net) of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Long-Term Investments Change (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $147.62 | $43.6 | $129.48 | – |
| 2021 | $24.34 | $100.43 | $-10.91 | $-280.09 | $-166.23 |
| 2020 | $92.07 | $-44.5 | $-128.79 | $42.5 | $-38.72 |
| 2019 | $-15.15 | $-197.75 | – | – | $-212.9 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology